Genmab

We track 4 ClinicalTrials.gov studies led by Genmab. The portfolio skews toward Phase 2 (3 trials).

4 clinical trials sponsored by Genmab.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 3
75%
Phase 3 1
25%

Trial Status Breakdown

Trials by Genmab

A Phase 2, Open-label, Multicohort Study of Rinatabart Sesutecan (Rina-S) in Participants With Non-Small Cell Lung Cancer

NCT07288177 · RECRUITING · Phase 2

A Prospective, Open-Label, Randomized, Phase 3 Trial of Acasunlimab (GEN1046) in Combination With Pembrolizumab Versus Docetaxel in Subjects With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer After Treatment With a PD-1/PD-L1 Inhibitor and Platinum-Containing Chemotherapy (ABBIL1TY NSCLC-06)

NCT06635824 · ACTIVE NOT RECRUITING · Phase 3

Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors

NCT05579366 · RECRUITING · Phase 2

A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors

NCT04083599 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Genmab sponsor?

Genmab currently sponsors 4 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 3.

What conditions does Genmab research?

Genmab conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Genmab recruiting for clinical trials?

Yes, Genmab currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More